Jensen, who as CEO led Nasdaq-listed biotech Allarity Therapeutics' refocusing around a single lead asset, cites Valion's ...
While biotech increasingly adopts AI for R&D, manufacturing bottlenecks constrain health innovation. AI and robotics have the ...
Investor's Business Daily on MSN
Biotech stocks tumble, with recent winners Moderna, Vaxcyte among the biggest losers
Biotech stocks took a hit Tuesday, with Vaxcyte, Moderna and Revolution Medicines posting some of the steepest losses.
VitroVivo Biotech LLC, a Maryland-based provider of histology and molecular histopathology products and laboratory services, is expanding access to specialized tissue-based research support through ...
Bayer is the world's 25th largest pharmaceutical company. New Albany will be its first manufacturing site of this kind in ...
Across the ARK Genomic Revolution ETF and the ARK Innovation ETF, Wood bought $6.1 million in Recursion Pharmaceuticals, $1.2 million in Intellia Therapeutics, and $5.3 million in Veracyte.
ArriVent Biopharma said its lung-cancer drug failed to meet long-term goals.
ArriVent BioPharma Inc. stocks have been trading down by -58.08 percent amid heightened concern over its latest clinical ...
ArriVent BioPharma Inc.’s stocks have been trading down by -57.66 percent amid heightened concern over its latest clinical ...
Using a short lapidated peptide (SLiP) developed by Mimetic Medicines disrupted a crucial voltage-gated sodium channel ...
The companies ADARx Pharmaceuticals, Electra Therapeutics, and Enveda bagged the biggest biotech funding rounds overall in ...
Dutch haul comes despite European drugmakers and investors warning the region is losing ground.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results